Search results
Results from the WOW.Com Content Network
The Marketed Health Products Directorate (MHPD) is the Canadian federal authority that monitors the safety and effectiveness of health products marketed in Canada. These include: [1] Prescription and non-prescription medications; Biologic medical products, including fractionated blood products; Therapeutic and diagnostic vaccines; Natural ...
Typically, clinical trials in human subjects are conducted and the results are provided as part of the clinical information package of a New Drug Submission (NDS) to Health Canada, the federal authority that reviews the safety and efficacy of human drugs. [2] Health Canada recognizes that there are circumstances in which sponsors cannot ...
Generic drug manufacturers often change the way in which prescription drug ingredients are made in order to lower costs of making them, so this kind of contamination may be more widespread and undetected in generic drugs. [21] 2022–2023 United States P. aeruginosa outbreak in eye drops
The Trump administration on Wednesday formally proposed a long-awaited plan to allow states to import certain prescription drugs from Canada, marking the first time that U.S. health agencies have ...
Health Canada (HC; French: Santé Canada, SC) [NB 1] is the department of the Government of Canada responsible for national health policy. The department itself is also responsible for numerous federal health-related agencies, including the Canadian Food Inspection Agency (CFIA) and the Public Health Agency of Canada (PHAC), among others.
According to Managed Care, an industry magazine, about a million Americans a year get drugs from licensed Canadian pharmacies that are certified by CIPA. Sen. John McCain (R-AZ), Sen. Bernie Sanders (D-VT), and five other sponsors have introduced legislation that would allow Americans with a U.S. prescription to order a 90-day supply of ...
Pfizer is recalling more than 4 million tablet packs of a prescription migraine treatment that do not meet child-resistant packaging requirements.
The FDA has recalled thousands of bottles of the antidepressant duloxetine, sold under brand name Cymbalta, due to the presence of a possibly cancer-causing chemical.